A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis

NCT02464020 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Primary Sclerosing Cholangitis
Inflammatory Bowel Disease

Interventions

DRUG: Vancomycin

Sponsor

University of Minnesota